Despite the importance of immune checkpoint inhibitors (ICPI) in the treatment of melanoma, current methods for PDL1 immunohistochemistry (IHC) do not allow interpretation when the tumor contains abundant melanin that obscures the IHC stain. This evidence concerns the gene CD274 and neoplasm.